{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:13:36Z","timestamp":1792156416697,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00595-026-03247-7","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T11:47:25Z","timestamp":1770637645000},"page":"1369-1374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The prognostic significance and clinical application of Mac-2 binding protein glycosylation Isomer, Lectin-Reactive \u03b1-Fetoprotein Fraction, and protein induced by vitamin K Absence-II in resectable hepatocellular carcinoma"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9876-2078","authenticated-orcid":false,"given":"Yoriko","family":"Nomura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Harimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Takeishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"3247_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"3247_CR2","doi-asserted-by":"publisher","first-page":"0","DOI":"10.1159\/000538627","volume":"13","author":"K Akahoshi","year":"2024","unstructured":"Akahoshi K, Shindoh J, Tanabe M, Ariizumi S, Eguchi S, Okamura Y, et al. Oncological resectability criteria for hepatocellular carcinoma in the era of novel systemic therapies: the Japan liver cancer association and Japanese society of hepato-biliary-pancreatic surgery expert consensus statement 2023. Liver Cancer. 2024;13:0\u201310. https:\/\/doi.org\/10.1159\/000538627.","journal-title":"Liver Cancer"},{"key":"3247_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/00000658-200203000-00009","volume":"235","author":"RTP Poon","year":"2002","unstructured":"Poon RTP, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg. 2002;235:373\u201382. https:\/\/doi.org\/10.1097\/00000658-200203000-00009.","journal-title":"Ann Surg"},{"key":"3247_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1477-2574.2012.00552.x","volume":"15","author":"J Shindoh","year":"2013","unstructured":"Shindoh J, Hasegawa K, Inoue Y, Ishizawa T, Nagata R, Aoki T, et al. Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma. HPB (Oxford). 2013;15:31\u20139. https:\/\/doi.org\/10.1111\/j.1477-2574.2012.00552.x.","journal-title":"HPB (Oxford)"},{"key":"3247_CR5","doi-asserted-by":"publisher","first-page":"e87011","DOI":"10.1371\/journal.pone.0087011","volume":"9","author":"J Cheng","year":"2014","unstructured":"Cheng J, Wang W, Zhang Y, Liu X, Li M, Wu Z, et al. Prognostic role of pretreatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis. PLoS ONE. 2014;9:e87011. https:\/\/doi.org\/10.1371\/journal.pone.0087011.","journal-title":"PLoS ONE"},{"key":"3247_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3892\/or_00000888","volume":"24","author":"D Nakatsura","year":"2010","unstructured":"Nakatsura D, Kato Y, Gotohda N. Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma. Oncol Rep. 2010;24:521\u20138. https:\/\/doi.org\/10.3892\/or_00000888.","journal-title":"Oncol Rep"},{"issue":"Suppl 1","key":"3247_CR7","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000111707","volume":"72","author":"DY Kim","year":"2007","unstructured":"Kim DY, Paik YH, Ahn SH, Youn YJ, Choi JW, Kim JK, et al. PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology. 2007;72(Suppl 1):52\u20137. https:\/\/doi.org\/10.1159\/000111707.","journal-title":"Oncology"},{"key":"3247_CR8","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1245\/s10434-021-11011-z","volume":"29","author":"K Yugawa","year":"2022","unstructured":"Yugawa K, Maeda T, Nagata S, Sakai A, Edagawa M, Omine T, et al. Mac-2-Binding protein glycosylation isomer as a novel predictor of hepatocellular carcinoma recurrence in patients with hepatitis C virus eradication. Ann Surg Oncol. 2022;29:2711\u20139. https:\/\/doi.org\/10.1245\/s10434-021-11011-z.","journal-title":"Ann Surg Oncol"},{"key":"3247_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3892\/mco.2021.2336","volume":"15","author":"K Tabu","year":"2021","unstructured":"Tabu K, Mawatari S, Oda K, Taniyama O, Toyodome A, Ijuin S, et al. Highly sensitive lens culinaris agglutinin-reactive fraction of \u03b1-fetoprotein is a predictive marker for hepatocarcinogenesis in long-term observation of patients with chronic liver disease. Mol Clin Oncol. 2021;15:174. https:\/\/doi.org\/10.3892\/mco.2021.2336.","journal-title":"Mol Clin Oncol"},{"key":"3247_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/jgh.13708","volume":"32","author":"Y Bekki","year":"2017","unstructured":"Bekki Y, Yoshizumi T, Shimoda S, Itoh S, Harimoto N, Ikegami T, et al. Hepatic stellate cells secreting WFA+ -M2BP: its role in biological interactions with Kupffer cells. J Gastroenterol Hepatol. 2017;32:1387\u201393. https:\/\/doi.org\/10.1111\/jgh.13708.","journal-title":"J Gastroenterol Hepatol"},{"key":"3247_CR11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3343\/alm.2021.41.1.16","volume":"41","author":"N Tamaki","year":"2021","unstructured":"Tamaki N, Kurosaki M, Loomba R, Izumi N. Clinical utility of Mac-2 binding protein glycosylation isomer in chronic liver diseases. Ann Lab Med. 2021;41:16\u201324. https:\/\/doi.org\/10.3343\/alm.2021.41.1.16.","journal-title":"Ann Lab Med"},{"key":"3247_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s41416-020-0971-y","volume":"123","author":"G Dolgormaa","year":"2020","unstructured":"Dolgormaa G, Harimoto N, Ishii N, Yamanaka T, Hagiwara K, Tsukagoshi M, et al. Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling. Br J Cancer. 2020;123:1145\u201353. https:\/\/doi.org\/10.1038\/s41416-020-0971-y.","journal-title":"Br J Cancer"},{"key":"3247_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00535-024-02179-8","volume":"60","author":"Y Kamada","year":"2025","unstructured":"Kamada Y, Sumida Y, Takahashi H, Fujii H, Miyoshi E, Nakajima A, et al. Utility of Mac-2 binding protein glycosylation isomer as an excellent biomarker for the prediction of liver fibrosis, activity, and hepatocellular carcinoma onset: an expert review. J Gastroenterol. 2025;60:10\u201323. https:\/\/doi.org\/10.1007\/s00535-024-02179-8.","journal-title":"J Gastroenterol"},{"key":"3247_CR14","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.jhep.2023.08.020","volume":"79","author":"JS Norman","year":"2023","unstructured":"Norman JS, Li PJ, Kotwani P, Shui AM, Yao F, Mehta N. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation. J Hepatol. 2023;79:1469\u201377. https:\/\/doi.org\/10.1016\/j.jhep.2023.08.020.","journal-title":"J Hepatol"},{"key":"3247_CR15","doi-asserted-by":"publisher","first-page":"102038","DOI":"10.1016\/j.gassur.2025.102038","volume":"29","author":"MD Wang","year":"2025","unstructured":"Wang MD, Wang BD, Diao YK, Li C, Yao LQ, Liu H, et al. Tumor biology characteristics score based on alpha-fetoprotein and protein induced by vitamin K absence or antagonist II as a predictor for recurrence and survival after curative resection for hepatocellular carcinoma: a multicenter cohort study. J Gastrointest Surg. 2025;29:102038. https:\/\/doi.org\/10.1016\/j.gassur.2025.102038.","journal-title":"J Gastrointest Surg"},{"key":"3247_CR16","doi-asserted-by":"publisher","first-page":"377","DOI":"10.17998\/jlc.2023.08.24","volume":"23","author":"S Yu","year":"2023","unstructured":"Yu S, Jo HS, Yu YD, Choi YJ, Kim DS. Clinical outcome of surgical resection for multifocal T2-T3 hepatocellular carcinoma up to 3 nodules: a comparative analysis with a single nodule. J Liver Cancer. 2023;23:377\u201388. https:\/\/doi.org\/10.17998\/jlc.2023.08.24.","journal-title":"J Liver Cancer"},{"key":"3247_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00595-024-02885-z","volume":"55","author":"K Yugawa","year":"2025","unstructured":"Yugawa K, Maeda T, Tsuji K, Shimokawa M, Sakai A, Yamaguchi S, et al. Mac-2 binding protein glycosylation isomer as a novel predictor of early recurrence after resection for hepatocellular carcinoma. Surg Today. 2025;55:62\u20139. https:\/\/doi.org\/10.1007\/s00595-024-02885-z.","journal-title":"Surg Today"},{"key":"3247_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1872-034X.2012.01004.x","volume":"42","author":"Y Saito","year":"2012","unstructured":"Saito Y, Shimada M, Utsunomiya T, Morine Y, Imura S, Ikemoto T, et al. Prediction of recurrence of hepatocellular carcinoma after curative hepatectomy using preoperative lens culinaris agglutinin-reactive fraction of alpha-fetoprotein. Hepatol Res. 2012;42:887\u201394. https:\/\/doi.org\/10.1111\/j.1872-034X.2012.01004.x.","journal-title":"Hepatol Res"},{"key":"3247_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3109\/00365521.2015.1082190","volume":"51","author":"TS Lim","year":"2016","unstructured":"Lim TS, Kim DY, Han KH, Kim HS, Shin SH, Jung KS, et al. Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients. Scand J Gastroenterol. 2016;51:344\u201353. https:\/\/doi.org\/10.3109\/00365521.2015.1082190.","journal-title":"Scand J Gastroenterol"},{"key":"3247_CR20","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.7150\/jca.112394","volume":"16","author":"SY Liu","year":"2025","unstructured":"Liu SY, Dai MG, Lu WF, Liang L, Liu JW, Li ZK, et al. Prognostic value of Des-gamma-carboxy prothrombin in AFP-negative hepatocellular carcinoma patients following liver resection: A multicenter study. J Cancer. 2025;16:2680\u20139. https:\/\/doi.org\/10.7150\/jca.112394.","journal-title":"J Cancer"},{"key":"3247_CR21","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3748\/wjg.14.1370","volume":"14","author":"K Hakamada","year":"2008","unstructured":"Hakamada K, Kimura N, Miura T, Morohashi H, Ishido K, Nara M, et al. Des-gamma-carboxy prothrombin as an important prognostic indicator in patients with small hepatocellular carcinoma. World J Gastroenterol. 2008;14:1370\u20137. https:\/\/doi.org\/10.3748\/wjg.14.1370.","journal-title":"World J Gastroenterol"},{"key":"3247_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1349-7006.2011.01875.x","volume":"102","author":"H Toyoda","year":"2011","unstructured":"Toyoda H, Kumada T, Tada T, Kaneoka Y, Maeda A, Kanke F, et al. Clinical utility of highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein\u2009<\u200920 ng\/mL. Cancer Sci. 2011;102:1025\u201331. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01875.x.","journal-title":"Cancer Sci"},{"key":"3247_CR23","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1007\/s00595-021-02427-x","volume":"52","author":"T Matsumoto","year":"2022","unstructured":"Matsumoto T, Kitano Y, Imai K, Kinoshita S, Sato H, Shiraishi Y, et al. Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy. Surg Today. 2022;52:1008\u201315. https:\/\/doi.org\/10.1007\/s00595-021-02427-x.","journal-title":"Surg Today"},{"key":"3247_CR24","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s00595-021-02440-0","volume":"52","author":"K Yugawa","year":"2022","unstructured":"Yugawa K, Maeda T, Nagata S, Sakai A, Edagawa M, Omine T, et al. A novel combined prognostic nutritional index and aspartate aminotransferase-to-platelet ratio index-based score can predict the survival of patients with hepatocellular carcinoma who undergo hepatic resection. Surg Today. 2022;52:1096\u2013108. https:\/\/doi.org\/10.1007\/s00595-021-02440-0.","journal-title":"Surg Today"},{"key":"3247_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00432-023-05526-z","volume":"150","author":"A Olbrich","year":"2024","unstructured":"Olbrich A, Niemeyer J, Seiffert H, Ebel S, Gros O, Lordick F, et al. The GALAD score and the BALAD-2 score correlate with transarterial and systemic treatment response and survival in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2024;150:81. https:\/\/doi.org\/10.1007\/s00432-023-05526-z.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3247_CR26","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1111\/liv.14406","volume":"40","author":"J Yoo","year":"2020","unstructured":"Yoo J, Lee MW, Lee DH, Lee JH, Han JK. Evaluation of a serum tumour marker-based recurrence prediction model after radiofrequency ablation for hepatocellular carcinoma. Liver Int. 2020;40:1189\u2013200. https:\/\/doi.org\/10.1111\/liv.14406.","journal-title":"Liver Int"},{"key":"3247_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3350\/cmh.2022.0212","volume":"29","author":"DY Kim","year":"2023","unstructured":"Kim DY, Toan BN, Tan CK, Hasan I, Setiawan L, Yu ML, et al. Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region. Clin Mol Hepatol. 2023;29:277\u201392. https:\/\/doi.org\/10.3350\/cmh.2022.0212.","journal-title":"Clin Mol Hepatol"},{"key":"3247_CR28","doi-asserted-by":"publisher","first-page":"e5811","DOI":"10.1097\/MD.0000000000005811","volume":"96","author":"SJ Park","year":"2017","unstructured":"Park SJ, Jang JY, Jeong SW, Cho YK, Lee SH, Kim SG, et al. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma. Med (Baltim). 2017;96:e5811. https:\/\/doi.org\/10.1097\/MD.0000000000005811.","journal-title":"Med (Baltim)"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03247-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03247-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03247-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:57:14Z","timestamp":1782395834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03247-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3247"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03247-7","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Declarations"}},{"value":"The authors declare no conflicts of interest for this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board of the Kyushu Medical Center (approval no. 25C092).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Approval of the research protocol by an institutional reviewer board"}},{"value":"Because of the retrospective design, an opt-out approach was employed instead of written informed consent in accordance with the institutional guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Registry and the registration No. of the study"}},{"value":"N\/A.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal studies"}}]}}